Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × cediranib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 9 Glioblastoma 8 Colorectal Neoplasms 8 Fallopian Tube Neoplasms 7 Breast Neoplasms 7 Rectal Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Gliosarcoma 6 Colonic Neoplasms 6 Brain Neoplasms 6 Carcinoma, Renal Cell 5 Melanoma 4 Uterine Cervical Neoplasms 3 Sarcoma, Alveolar Soft Part 3 Sarcoma 3 Prostatic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms, Male 3 Uveal Melanoma 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1

Interventions

Gemcitabine 78 Cisplatin 62 Capecitabine 32 Oxaliplatin 30 durvalumab 24 Fluorouracil 22 pembrolizumab 21 Leucovorin 20 S 1 (combination) 14 Irinotecan 12 lenvatinib 10 Nivolumab 10 Bevacizumab 9 130-nm albumin-bound paclitaxel 9 tremelimumab 7 Injections 7 Immune Checkpoint Inhibitors 7 Docetaxel 7 apatinib 6 Trastuzumab 6 surufatinib 5 irinotecan sucrosofate 5 camrelizumab 5 Folfox protocol 5 Carboplatin 5 Blood Specimen Collection 5 Albumin-Bound Paclitaxel 5 titanium silicide 4 gemcitabine-oxaliplatin regimen 4 envafolimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00939848 2014-10-27

ABC-03

University College, London

Phase 2/3 Completed

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡